Granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
stimulates	O
JAK2	B-protein
signaling	O
pathway	O
and	O
rapidly	O
activates	O
p93fes	B-protein
,	O
STAT1	B-protein
p91	I-protein
,	O
and	O
STAT3	B-protein
p92	I-protein
in	O
polymorphonuclear	B-cell_type
leukocytes	I-cell_type
.	O

Granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
(	O
GM-CSF	B-protein
)	O
,	O
supports	O
proliferation	O
,	O
differentiation	O
,	O
and	O
functional	O
activation	O
of	O
hemopoietic	O
cells	O
by	O
its	O
interaction	O
with	O
a	O
heterodimeric	O
receptor	O
.	O

Although	O
GM-CSF	B-protein
receptor	O
is	O
devoid	O
of	O
tyrosine	B-protein
kinase	I-protein
enzymatic	O
activity	O
,	O
GM-CSF-induced	B-cell_line
peripheral	I-cell_line
blood	I-cell_line
polymorphonuclear	I-cell_line
leukocytes	I-cell_line
(	O
PMN	B-cell_type
)	O
functional	O
activation	O
is	O
mediated	O
by	O
the	O
phosphorylation	O
of	O
a	O
large	O
number	O
of	O
intracellular	B-protein
signaling	I-protein
molecules	I-protein
.	O

We	O
have	O
previously	O
shown	O
that	O
JAK2	B-protein
becomes	O
tyrosine-phosphorylated	O
in	O
response	O
to	O
GM-CSF	B-protein
in	O
PMN	B-cell_type
.	O

In	O
the	O
present	O
study	O
we	O
demonstrate	O
that	O
also	O
the	O
signal	B-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
(	I-protein
STAT	I-protein
)	I-protein
family	I-protein
members	I-protein
STAT1	B-protein
p91	I-protein
and	O
STAT3	B-protein
p92	I-protein
and	O
the	O
product	O
of	O
the	O
c-fps/fes	B-DNA
protooncogene	I-DNA
become	O
tyrosine-phosphorylated	O
upon	O
GM-CSF	B-protein
stimulation	O
and	O
physically	O
associated	O
with	O
both	O
GM-CSF	B-protein
receptor	O
beta	O
common	O
subunit	O
and	O
JAK2	B-protein
.	O

Moreover	O
GM-CSF	B-protein
was	O
able	O
to	O
induce	O
JAK2	B-protein
and	O
p93fes	B-protein
catalytic	O
activity	O
.	O

We	O
also	O
demonstrate	O
that	O
the	O
association	O
of	O
the	O
GM-CSF	B-protein
receptor	I-protein
beta	I-protein
common	I-protein
subunit	I-protein
with	O
JAK2	B-protein
is	O
ligand-dependent	O
.	O

Finally	O
we	O
demonstrate	O
that	O
GM-CSF	B-protein
induces	O
a	O
DNA-binding	B-protein
complex	I-protein
that	O
contains	O
both	O
p91	B-protein
and	O
p92	B-protein
.	O

These	O
results	O
identify	O
a	O
new	O
signal	O
transduction	O
pathway	O
activated	O
by	O
GM-CSF	B-protein
and	O
provide	O
a	O
mechanism	O
for	O
rapid	O
activation	O
of	O
gene	O
expression	O
in	O
GM-CSF-stimulated	B-cell_type
PMN	I-cell_type
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

7	NULL
,	NULL
Issue	NULL
of	NULL
February	NULL
16	NULL
,	NULL
pp	NULL
.	NULL

3562-3567	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Granulocyte-Macrophage	NULL
Colony-stimulating	NULL
Factor	NULL
Stimulates	NULL
JAK2	NULL
Signaling	NULL
Pathway	NULL
and	NULL
Rapidly	NULL
Activates	NULL
p93	NULL
``	NULL
,	NULL
STAT1	NULL
p91	NULL
,	NULL
and	NULL
STAT3	NULL
p92	NULL
in	NULL
Polymorphonuclear	NULL
Leukocytes*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
August	NULL
18	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
November	NULL
8	NULL
,	NULL
1995	NULL
)	NULL
Maria	NULL
F.	NULL
Brizzi	NULL
#	NULL
,	NULL
Maria	NULL
G.	NULL
Aronica	NULL
$	NULL
§	NULL
,	NULL
Arturo	NULL
Rosso	NULL
,	NULL
Gian	NULL
Paolo	NULL
Bagnara	NULL
,	NULL
Yosef	NULL
Yarden|	NULL
,	NULL
and	NULL
Luigi	NULL
Pegoraro	NULL
?	NULL
}	NULL

**	NULL
From	NULL
the	NULL
{	NULL
Dipartimento	NULL
di	NULL
Scienze	NULL
Biomediche	NULL
e	NULL
Oncologia	NULL
Umana	NULL
,	NULL
Université	NULL
di	NULL
Torino	NULL
,	NULL
10126	NULL
Torino	NULL
,	NULL
Italy	NULL
,	NULL
the	NULL
Istituto	NULL
di	NULL
Istologia	NULL
ed	NULL
Embriologia	NULL
,	NULL
Centro	NULL
Interdipartimentale	NULL
di	NULL
Ricerca	NULL
Giorgio	NULL
Prodi	NULL
,	NULL
Universita	NULL
di	NULL
Bologna	NULL
,	NULL
Bologna	NULL
,	NULL
Italy	NULL
40126	NULL
,	NULL
and	NULL
the	NULL
|Department	NULL
of	NULL
Chemical	NULL
Immunology	NULL
,	NULL
The	NULL
Weizmann	NULL
Institute	NULL
of	NULL
Science	NULL
,	NULL
Rehovot	NULL
,	NULL
Israel	NULL
76100	NULL
Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
supports	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
functional	NULL
activation	NULL
of	NULL
hemopoietic	NULL
cells	NULL
by	NULL
its	NULL
interaction	NULL
with	NULL
a	NULL
heterodimeric	NULL
receptor	NULL
.	NULL

Although	NULL
GM-CSF	NULL
receptor	NULL
is	NULL
devoid	NULL
of	NULL
tyrosine	NULL
kinase	NULL
enzymatic	NULL
activity	NULL
,	NULL
GM-CSF-induced	NULL
peripheral	NULL
blood	NULL
polymorphonuclear	NULL
leukocytes	NULL
(	NULL
PMN	NULL
)	NULL
functional	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
phosphorylation	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
intracellular	NULL
signaling	NULL
molecules	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
JAK2	NULL
becomes	NULL
tyrosine-phosphorylated	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
in	NULL
PMN	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
demonstrate	NULL
that	NULL
also	NULL
the	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
family	NULL
members	NULL
STAT1	NULL
p91	NULL
and	NULL
STAT3	NULL
p92	NULL
and	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-fps/fes	NULL
protooncogene	NULL
become	NULL
tyrosine-phosphorylated	NULL
upon	NULL
GM-CSF	NULL
stimulation	NULL
and	NULL
physically	NULL
associated	NULL
with	NULL
both	NULL
GM-CSF	NULL
receptor	NULL
B	NULL
common	NULL
subunit	NULL
and	NULL
JAK2	NULL
.	NULL

Moreover	NULL
GM-CSF	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
JAK2	NULL
and	NULL
p93	NULL
'	NULL
``	NULL
``	NULL
catalytic	NULL
activity	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
that	NULL
the	NULL
association	NULL
of	NULL
the	NULL
GM-CSF	NULL
receptor	NULL
B	NULL
common	NULL
subunit	NULL
with	NULL
JAK2	NULL
is	NULL
ligand-dependent	NULL
.	NULL

Finally	NULL
we	NULL
demonstrate	NULL
that	NULL
GM-CSF	NULL
induces	NULL
a	NULL
DNA-binding	NULL
complex	NULL
that	NULL
contains	NULL
both	NULL
p91	NULL
and	NULL
p92	NULL
.	NULL

These	NULL
results	NULL
identify	NULL
a	NULL
new	NULL
signal	NULL
transduction	NULL
pathway	NULL
activated	NULL
by	NULL
GM-CSF	NULL
and	NULL
provide	NULL
a	NULL
mechanism	NULL
for	NULL
rapid	NULL
activation	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
GM-CSF-stimulated	NULL
PMN	NULL
.	NULL

Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
regulates	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
hemopoietic	NULL
progenitor	NULL
cells	NULL
and	NULL
functionally	NULL
activates	NULL
polymorphonuclear	NULL
leukocytes	NULL
(	NULL
PMN	NULL
)	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
GM-CSF	NULL
exerts	NULL
several	NULL
direct	NULL
actions	NULL
on	NULL
neutrophils	NULL
,	NULL
including	NULL
stimulation	NULL
of	NULL
changes	NULL
in	NULL
surface	NULL
expression	NULL
of	NULL
both	NULL
chemotactic	NULL
receptors	NULL
and	NULL
adherence	NULL
proteins	NULL
(	NULL
2-5	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
hydrogen	NULL
peroxide	NULL
production	NULL
by	NULL
neutrophils	NULL
adhered	NULL
to	NULL
extracellular	NULL
matrix	NULL
components	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Moreover	NULL
GM-CSF	NULL
has	NULL
indirect	NULL
effects	NULL
on	NULL
neu-	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Associazione	NULL
Italiana	NULL
Ricerca	NULL
sul	NULL
Canero	NULL
(	NULL
AIRC	NULL
)	NULL
,	NULL
by	NULL
CNR	NULL
,	NULL
Progetto	NULL
Finalizzato	NULL
A.C.R.O	NULL
.	NULL

,	NULL
and	NULL
by	NULL
ISS	NULL
VII	NULL
Progetto	NULL
AIDS	NULL
.	NULL

§	NULL
Fellow	NULL
of	NULL
AIRC	NULL
.	NULL

**To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dipartimento	NULL
di	NULL
Scienze	NULL
Biomediche	NULL
e	NULL
Oncologia	NULL
Umana	NULL
,	NULL
Sezione	NULL
Clinica	NULL
,	NULL
Universita	NULL
di	NULL
Torino	NULL
,	NULL
Via	NULL
Genova	NULL
3	NULL
,	NULL
10126	NULL
,	NULL
Torino	NULL
.	NULL

Tel./Fax	NULL
:	NULL
39-11-663-7520	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
rh	NULL
,	NULL
recombinant	NULL
human	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
;	NULL
PMN	NULL
,	NULL
polymorphonuclear	NULL
neutrophils	NULL
;	NULL
Pipes	NULL
,	NULL
1,4-piperazinediethanesulfonic	NULL
acid	NULL
.	NULL

trophils	NULL
,	NULL
such	NULL
as	NULL
``	NULL
priming	NULL
``	NULL
these	NULL
cells	NULL
for	NULL
enhanced	NULL
responses	NULL
to	NULL
a	NULL
number	NULL
of	NULL
physiologically	NULL
relevant	NULL
stimuli	NULL
such	NULL
as	NULL
ingestion	NULL
of	NULL
Staphylococcus	NULL
aureus	NULL
(	NULL
8	NULL
)	NULL
,	NULL
serum-opsonized	NULL
particles	NULL
(	NULL
3	NULL
)	NULL
,	NULL
antibody-dependent	NULL
cytotoxicity	NULL
(	NULL
3	NULL
)	NULL
,	NULL
fMet-Leu-Phe	NULL
(	NULL
FMLP	NULL
)	NULL
-stimulated	NULL
intracellular	NULL
calcium	NULL
mobilization	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
oxyradi-cal	NULL
(	NULL
2	NULL
,	NULL
10	NULL
)	NULL
and	NULL
platelet-activating	NULL
factor	NULL
(	NULL
11	NULL
)	NULL
production	NULL
as	NULL
well	NULL
as	NULL
leukotriene	NULL
synthesis	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
GM-CSF	NULL
inhibits	NULL
programmed	NULL
cell	NULL
death	NULL
both	NULL
in	NULL
human	NULL
eosinophils	NULL
and	NULL
neutrophils	NULL
(	NULL
15	NULL
)	NULL
and	NULL
that	NULL
this	NULL
effect	NULL
is	NULL
mediated	NULL
by	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
intracellular	NULL
substrates	NULL
(	NULL
15	NULL
)	NULL
.	NULL

All	NULL
GM-CSF	NULL
effects	NULL
are	NULL
mediated	NULL
by	NULL
a	NULL
heterodimeric	NULL
receptor	NULL
comprised	NULL
of	NULL
a	NULL
ligand	NULL
binding	NULL
subunit	NULL
,	NULL
denoted	NULL
a	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
of	NULL
a	NULL
transducing	NULL
subunit	NULL
designated	NULL
as	NULL
B	NULL
(	NULL
17	NULL
)	NULL
,	NULL
which	NULL
is	NULL
also	NULL
shared	NULL
with	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
(	NULL
17	NULL
)	NULL
and	NULL
IL-5	NULL
receptor	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Although	NULL
GM-CSF	NULL
receptor	NULL
does	NULL
not	NULL
possess	NULL
an	NULL
intrinsic	NULL
tyrosine	NULL
kinase	NULL
domain	NULL
,	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
signaling	NULL
processes	NULL
initiated	NULL
by	NULL
ligand	NULL
binding	NULL
to	NULL
the	NULL
receptor	NULL
induce	NULL
activation	NULL
of	NULL
cellular	NULL
tyrosine	NULL
kinases	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
biochemical	NULL
interaction	NULL
involved	NULL
in	NULL
signaling	NULL
from	NULL
the	NULL
GM-CSF	NULL
receptor	NULL
have	NULL
demonstrated	NULL
that	NULL
a	NULL
number	NULL
of	NULL
transducing	NULL
molecules	NULL
such	NULL
as	NULL
She	NULL
(	NULL
20-22	NULL
)	NULL
,	NULL
Grb2	NULL
(	NULL
20	NULL
)	NULL
,	NULL
Sos1	NULL
(	NULL
20	NULL
)	NULL
,	NULL
Ras	NULL
(	NULL
23	NULL
)	NULL
,	NULL
Raf-1	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
25	NULL
)	NULL
become	NULL
activated	NULL
upon	NULL
GM-CSF	NULL
stimulation	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
that	NULL
a	NULL
nonreceptor	NULL
tyrosine	NULL
kinase	NULL
,	NULL
the	NULL
c-fps/fes	NULL
protooncogene	NULL
prod-uct	NULL
,	NULL
is	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
(	NULL
26	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
the	NULL
receptor-associated	NULL
protein	NULL
JAK2	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
rapidly	NULL
phosphorylated	NULL
upon	NULL
GM-CSF	NULL
receptor	NULL
activation	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Recent	NULL
data	NULL
suggest	NULL
that	NULL
at	NULL
least	NULL
two	NULL
components	NULL
of	NULL
latent	NULL
cytoplasmic	NULL
proteins	NULL
termed	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
's	NULL
)	NULL
(	NULL
31	NULL
)	NULL
,	NULL
which	NULL
become	NULL
activated	NULL
upon	NULL
ligand	NULL
binding	NULL
,	NULL
are	NULL
substrates	NULL
of	NULL
JAK	NULL
family	NULL
members	NULL
(	NULL
32-34	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
characterize	NULL
the	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
involved	NULL
in	NULL
GM-CSF-mediated	NULL
PMN	NULL
activation	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
two	NULL
STAT	NULL
proteins	NULL
,	NULL
STAT1I	NULL
a	NULL
(	NULL
p91	NULL
)	NULL
and	NULL
STAT3	NULL
(	NULL
p92	NULL
)	NULL
and	NULL
of	NULL
c-fps/fes	NULL
protooncogene	NULL
product	NULL
(	NULL
p93	NULL
``	NULL
®	NULL
)	NULL
in	NULL
this	NULL
process	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
,	NULL
upon	NULL
GM-CSF	NULL
stimulation	NULL
,	NULL
both	NULL
STAT	NULL
proteins	NULL
and	NULL
p93/*	NULL
``	NULL
become	NULL
tyrosine-phosphorylated	NULL
and	NULL
physically	NULL
associate	NULL
with	NULL
GM-CSF	NULL
receptor	NULL
B	NULL
common	NULL
subunit	NULL
as	NULL
well	NULL
as	NULL
with	NULL
JAK2	NULL
.	NULL

GM-CSF	NULL
stimulation	NULL
was	NULL
also	NULL
able	NULL
to	NULL
induce	NULL
p93	NULL
``	NULL
and	NULL
JAK2	NULL
catalytic	NULL
activity	NULL
.	NULL

Moreover	NULL
we	NULL
demonstrate	NULL
that	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
for	NULL
erythropoietin	NULL
receptor	NULL
(	NULL
35	NULL
)	NULL
,	NULL
JAK2	NULL
association	NULL
with	NULL
the	NULL
B	NULL
common	NULL
subunit	NULL
is	NULL
ligand-dependent	NULL
.	NULL

Finally	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
DNA-binding	NULL
proteins	NULL
p91	NULL
and	NULL
p92	NULL
are	NULL
early	NULL
targets	NULL
of	NULL
the	NULL
GM-CSF-induced	NULL
DNA-binding	NULL
complex	NULL
.	NULL

These	NULL
results	NULL
identify	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
that	NULL
is	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
in	NULL
human	NULL
PMN	NULL
and	NULL
provide	NULL
evidence	NULL
for	NULL
3562	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Signaling	NULL
in	NULL
PMN	NULL
Functional	NULL
Activation	NULL
3563	NULL
the	NULL
role	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
GM-CSF-mediated	NULL
rapid	NULL
modulation	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
functionally	NULL
activated	NULL
nonproliferat-ing	NULL
cells	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Reagents-Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Life	NULL
Technol-ogies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Bovine	NULL
calf	NULL
serum	NULL
was	NULL
from	NULL
Hyclone	NULL
Laboratories	NULL
(	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
.	NULL

Gelatin	NULL
was	NULL
from	NULL
Difco	NULL
.	NULL

rhGM-CSFs	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Sandoz	NULL
Forschungsinstitut	NULL
,	NULL
Austria	NULL
.	NULL

rhIL-3	NULL
and	NULL
rhIL-6	NULL
were	NULL
a	NULL
gift	NULL
from	NULL
Genetic	NULL
Institute	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
Sepharose-protein	NULL
A	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Nitrocellulose	NULL
filters	NULL
,	NULL
horseradish	NULL
peroxidase-conjugated	NULL
protein	NULL
A	NULL
,	NULL
molecular	NULL
weight	NULL
markers	NULL
,	NULL
[	NULL
a-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
,	NULL
[	NULL
y-*°P	NULL
]	NULL
ATP	NULL
,	NULL
and	NULL
the	NULL
chemiluminescence	NULL
reagent	NULL
(	NULL
ECL	NULL
)	NULL
,	NULL
were	NULL
from	NULL
Amersham	NULL
Corp.	NULL
Poly	NULL
(	NULL
dI-dC	NULL
)	NULL
:	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Pharmacia	NULL
(	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Antisera-Polyclonal	NULL
anti-IL-3/GM-CSF	NULL
receptor	NULL
B	NULL
common	NULL
subunit	NULL
antiserum	NULL
was	NULL
obtained	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Polyclonal	NULL
anti-c-fps/fes	NULL
antibody	NULL
was	NULL
prepared	NULL
from	NULL
serum	NULL
of	NULL
a	NULL
rabbit	NULL
immunized	NULL
against	NULL
a	NULL
synthetic	NULL
peptides	NULL
,	NULL
which	NULL
was	NULL
conjugated	NULL
to	NULL
keyhole	NULL
limpet	NULL
hemocyanin	NULL
by	NULL
gluteraldehyde	NULL
.	NULL

The	NULL
peptide	NULL
sequences	NULL
for	NULL
c-fps/fes	NULL
was	NULL
LLLQDDRHSTSSSEQEREGG	NULL
(	NULL
corresponding	NULL
to	NULL
amino	NULL
acid	NULL
residues	NULL
424-443	NULL
)	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
antisera	NULL
was	NULL
demonstrated	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
the	NULL
immunoprecipitation	NULL
band	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
saturating	NULL
concentrations	NULL
of	NULL
the	NULL
related	NULL
peptides	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Polyclonal	NULL
antibodies	NULL
to	NULL
p91	NULL
were	NULL
generated	NULL
in	NULL
rabbits	NULL
that	NULL
were	NULL
injected	NULL
with	NULL
a	NULL
synthetic	NULL
peptide	NULL
whose	NULL
sequence	NULL
corresponds	NULL
to	NULL
residues	NULL
84-96	NULL
of	NULL
human	NULL
transcription	NULL
factor	NULL
ISGR-3	NULL
(	NULL
GenBank	NULL
``	NULL
accession	NULL
number	NULL
M97935	NULL
)	NULL
:	NULL
RKSKRNLQDNFQEDC	NULL
.	NULL

Peptide	NULL
conjugation	NULL
to	NULL
a	NULL
carrier	NULL
protein	NULL
,	NULL
injection	NULL
to	NULL
rabbits	NULL
and	NULL
bleeding	NULL
were	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
86	NULL
)	NULL
.	NULL

Anti-phosphotyrosine	NULL
antibody	NULL
4G10	NULL
,	NULL
anti-JAK1	NULL
,	NULL
and	NULL
anti-JAK2	NULL
antisera	NULL
were	NULL
obtained	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Anti-STAT3	NULL
p92	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
obtained	NULL
from	NULL
Affinity	NULL
Research	NULL
Products	NULL
Ltd.	NULL
(	NULL
Nottingham	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
and	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
(	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Cells-Human	NULL
neutrophils	NULL
(	NULL
PMN	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
venous	NULL
blood	NULL
of	NULL
normal	NULL
donors	NULL
by	NULL
gelatin	NULL
sedimentation	NULL
(	NULL
2.5	NULL
%	NULL
gelatin	NULL
in	NULL
PBS	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
)	NULL
followed	NULL
by	NULL
Ficoll-Hypaque	NULL
gradient	NULL
separation	NULL
.	NULL

Contaminating	NULL
erythrocytes	NULL
were	NULL
removed	NULL
by	NULL
hypotonic	NULL
lysis	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
RPMI	NULL
1640	NULL
medium	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
%	NULL
10	NULL
``	NULL
cells/ml	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
neutrophils	NULL
in	NULL
cell	NULL
preparation	NULL
used	NULL
in	NULL
this	NULL
study	NULL
was	NULL
97	NULL
%	NULL
and	NULL
cell	NULL
viability	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
was	NULL
98	NULL
%	NULL
.	NULL

HEPG2	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
bovine	NULL
calf	NULL
serum	NULL
and	NULL
serum-starved	NULL
overnight	NULL
before	NULL
being	NULL
treated	NULL
with	NULL
rhIL-6	NULL
(	NULL
80	NULL
Western	NULL
Blot	NULL
Analysis	NULL
and	NULL
Immunoprecipitation	NULL
Studies-Cells	NULL
(	NULL
4	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
extracted	NULL
with	NULL
cold	NULL
DIM	NULL
buffer	NULL
(	NULL
50	NULL
mmol/liter	NULL
Pipes	NULL
,	NULL
pH	NULL
6.8	NULL
,	NULL
100	NULL
mmol/liter	NULL
NaCl	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
300	NULL
mmol/liter	NULL
sucrose	NULL
,	NULL
5	NULL
mmol/liter	NULL
EGTA	NULL
,	NULL
2	NULL
mmol/liter	NULL
sodium	NULL
orthovanadate	NULL
)	NULL
plus	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
and	NULL
a	NULL
mixture	NULL
of	NULL
protease	NULL
inhibitors	NULL
(	NULL
1	NULL
mmol/liter	NULL
phenylmethylsulfonyl	NULL
flu-oride	NULL
,	NULL
10	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
0.15	NULL
units/ml	NULL
aprotinin	NULL
,	NULL
1	NULL
ug/ml	NULL
pepstatin	NULL
A	NULL
)	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
centrifuged	NULL
at	NULL
15,000	NULL
x	NULL
g	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
clarified	NULL
supernatant	NULL
was	NULL
precleaned	NULL
for	NULL
1	NULL
h	NULL
with	NULL
50	NULL
ul	NULL
of	NULL
Sepharose	NULL
protein	NULL
A	NULL
(	NULL
3	NULL
mg/sample	NULL
)	NULL
.	NULL

The	NULL
precleared	NULL
cell	NULL
lysates	NULL
were	NULL
then	NULL
adsorbed	NULL
by	NULL
antisera	NULL
coupled	NULL
to	NULL
protein	NULL
A-Sepharose	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
washed	NULL
several	NULL
times	NULL
in	NULL
DIM	NULL
buffer	NULL
and	NULL
eluted	NULL
in	NULL
boiling	NULL
Laemmli	NULL
buffer	NULL
.	NULL

Eluted	NULL
proteins	NULL
were	NULL
subjected	NULL
to	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Proteins	NULL
were	NULL
then	NULL
transferred	NULL
electrophoretically	NULL
to	NULL
nitrocellulose	NULL
;	NULL
the	NULL
filters	NULL
were	NULL
incubated	NULL
with	NULL
blocking	NULL
solution	NULL
(	NULL
10	NULL
%	NULL
low	NULL
fat	NULL
milk	NULL
in	NULL
20	NULL
mmol/liter	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
and	NULL
17	NULL
mmol/liter	NULL
NaCl	NULL
)	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
Antisera	NULL
were	NULL
then	NULL
added	NULL
at	NULL
the	NULL
same	NULL
solution	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

For	NULL
detection	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
(	NULL
10	NULL
min	NULL
each	NULL
wash	NULL
)	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
reacted	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
protein	NULL
A	NULL
.	NULL

The	NULL
enzyme	NULL
was	NULL
removed	NULL
by	NULL
washing	NULL
as	NULL
above	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
reacted	NULL
for	NULL
1	NULL
min	NULL
with	NULL
a	NULL
chemiluminescence	NULL
reagent	NULL
(	NULL
ECL	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
an	NULL
autoradiog-raphy	NULL
film	NULL
for	NULL
1-15	NULL
min	NULL
.	NULL

To	NULL
reprobe	NULL
,	NULL
nitrocellulose	NULL
filters	NULL
were	NULL
first	NULL
stripped	NULL
of	NULL
antibody	NULL
by	NULL
62	NULL
mmol/liter	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
6.7	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
mmol/liter	NULL
B*-mercaptoethanol	NULL
.	NULL

In	NULL
Vitro	NULL
Kinase	NULL
Assay-Anti-JAK2	NULL
and	NULL
anti-p93'®	NULL
``	NULL
immunoprecipitates	NULL
were	NULL
washed	NULL
and	NULL
divided	NULL
into	NULL
two	NULL
equal	NULL
parts	NULL
.	NULL

One	NULL
part	NULL
was	NULL
resuspended	NULL
in	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
kinase	NULL
assay	NULL
buffer	NULL
(	NULL
50	NULL
mmol/liter	NULL
NaCl	NULL
,	NULL
5	NULL
mmol/liter	NULL
MgCl	NULL
,	NULL
,	NULL
5	NULL
mmol/liter	NULL
MnCl	NULL
,	NULL
0.1	NULL
mmol/liter	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
10	NULL
mmol/liter	NULL
Hepes	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
containing	NULL
[	NULL
y-°°P	NULL
]	NULL
JATP	NULL
(	NULL
0.25	NULL
uCi/ml	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
washed	NULL
,	NULL
eluted	NULL
with	NULL
sample	NULL
buffer	NULL
for	NULL
SDS-	NULL
amosr	NULL
-	NULL
+	NULL
--	NULL
D3	NULL
-	NULL
200	NULL
hoe	NULL
~	NULL
e	NULL
«	NULL
»	NULL
wo	NULL
an	NULL
__	NULL
,	NULL
;	NULL
,	NULL
IP	NULL
anti	NULL
IB	NULL
anti	NULL
JAK2	NULL
bota	NULL
--	NULL
«	NULL
ume	NULL
aan	NULL
1B	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

JAK2	NULL
association	NULL
with	NULL
the	NULL
GM-CSF	NULL
receptor	NULL
B	NULL
common	NULL
subunit	NULL
in	NULL
PMN	NULL
.	NULL

Cell	NULL
lysates	NULL
from	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
GM-CSF-stimulated	NULL
(	NULL
10	NULL
ng/ml	NULL
for	NULL
5	NULL
min	NULL
)	NULL
(	NULL
+	NULL
)	NULL
PMN	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-B	NULL
antiserum	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
also	NULL
immunoprecipitated	NULL
with	NULL
anti-JAK2	NULL
antiserum	NULL
to	NULL
indicate	NULL
the	NULL
p130	NULL
JAK2	NULL
protein	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
the	NULL
anti-JAK2	NULL
antiserum	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
reprobed	NULL
with	NULL
the	NULL
anti-B	NULL
antiserum	NULL
(	NULL
Fower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
p1830	NULL
JAK2	NULL
is	NULL
indicated	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitated	NULL
;	NULL
IB	NULL
,	NULL
immunoblotted	NULL
.	NULL

polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
separated	NULL
on	NULL
8	NULL
%	NULL
gel	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
;	NULL
the	NULL
other	NULL
part	NULL
was	NULL
separated	NULL
on	NULL
8	NULL
%	NULL
gel	NULL
and	NULL
probed	NULL
with	NULL
anti-JAK2	NULL
or	NULL
anti-p93'®	NULL
``	NULL
antisera	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extract	NULL
and	NULL
Gel	NULL
Retardation	NULL
Assay-Nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
and	NULL
GM-CSF-treated	NULL
PMN	NULL
and	NULL
untreated	NULL
and	NULL
IL-6-treated	NULL
HEPG2	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
Nonidet	NULL
P40	NULL
lysis	NULL
as	NULL
described	NULL
by	NULL
Sadowski	NULL
and	NULL
Gilman	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
were	NULL
G	NULL
GGG	NULL
CAT	NULL
TTC	NULL
CCG	NULL
TAA	NULL
ATC	NULL
and	NULL
G	NULL
GGG	NULL
GAT	NULL
TTA	NULL
CGG	NULL
GAA	NULL
ATG	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
annealed	NULL
oligonucleotide	NULL
was	NULL
labeled	NULL
by	NULL
filling	NULL
in	NULL
the	NULL
overhanging	NULL
ends	NULL
with	NULL
Klenow	NULL
fragment	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
«	NULL
-*	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
.	NULL

Gel	NULL
retardation	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
13	NULL
mmol/liter	NULL
Hepes	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
80	NULL
mmol/liter	NULL
NaCl	NULL
,	NULL
3	NULL
mmol/liter	NULL
NaF	NULL
,	NULL
3	NULL
mmol/liter	NULL
NaMo0	NULL
,	NULL
1	NULL
mmol/liter	NULL
dithiothreitol	NULL
,	NULL
0.15	NULL
mmol/liter	NULL
EDTA	NULL
,	NULL
0.15	NULL
mmol/liter	NULL
EGTA	NULL
,	NULL
and	NULL
8	NULL
%	NULL
glycerol	NULL
(	NULL
including	NULL
contribution	NULL
from	NULL
the	NULL
nuclear	NULL
extract	NULL
)	NULL
and	NULL
contained	NULL
75	NULL
pg/ml	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
:	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
approximately	NULL
0.3	NULL
ng	NULL
of	NULL
radiolabeled	NULL
probe	NULL
,	NULL
and	NULL
5-10	NULL
ug	NULL
of	NULL
protein	NULL
.	NULL

Reactions	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
40	NULL
min	NULL
and	NULL
then	NULL
resolved	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
containing	NULL
0.25	NULL
x	NULL
TBE	NULL
(	NULL
1	NULL
x	NULL
TBE	NULL
is	NULL
89	NULL
mmol/liter	NULL
Tris	NULL
borate	NULL
,	NULL
1	NULL
mmol/liter	NULL
EDTA	NULL
,	NULL
pH	NULL
8	NULL
)	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
.	NULL

Gels	NULL
were	NULL
run	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
0.25	NULL
x	NULL
TBE	NULL
at	NULL
20	NULL
V/em	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
autoradiographed	NULL
.	NULL

Oligonucleotide	NULL
competition	NULL
was	NULL
performed	NULL
by	NULL
preincubating	NULL
nuclear	NULL
extracts	NULL
with	NULL
the	NULL
competitor	NULL
oligonucleotide	NULL
(	NULL
50-fold	NULL
excess	NULL
)	NULL
and	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
:	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
labeled	NULL
probe	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
done	NULL
with	NULL
nuclear	NULL
extract	NULL
that	NULL
had	NULL
been	NULL
reacted	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
GM-CSF	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
host	NULL
defense	NULL
by	NULL
enhance-ing	NULL
the	NULL
functional	NULL
activities	NULL
of	NULL
mature	NULL
leukocytes	NULL
and	NULL
,	NULL
in	NULL
particular	NULL
,	NULL
neutrophils	NULL
(	NULL
2-14	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
GM-CSF	NULL
to	NULL
its	NULL
heterodimeric	NULL
receptor	NULL
,	NULL
which	NULL
is	NULL
devoid	NULL
of	NULL
intrinsic	NULL
kinase	NULL
activity	NULL
,	NULL
leads	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
cellular	NULL
substrates	NULL
(	NULL
19	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
,	NULL
in	NULL
growth	NULL
factor-dependent	NULL
cell	NULL
lines	NULL
,	NULL
JAK2	NULL
is	NULL
constitutively	NULL
associated	NULL
with	NULL
the	NULL
B	NULL
subunit	NULL
(	NULL
29-30	NULL
)	NULL
.	NULL

Moreover	NULL
JAK2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
phosphorylated	NULL
upon	NULL
growth	NULL
factor	NULL
stimulation	NULL
not	NULL
only	NULL
in	NULL
proliferating	NULL
cells	NULL
but	NULL
also	NULL
in	NULL
PMN	NULL
and	NULL
eosinophils	NULL
functionally	NULL
activated	NULL
by	NULL
GM-CSF	NULL
(	NULL
30	NULL
)	NULL
and	NULL
IL-5	NULL
(	NULL
38	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
ligand-dependent	NULL
association	NULL
of	NULL
JAK2	NULL
with	NULL
erythropoietin	NULL
receptor	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
(	NULL
35	NULL
)	NULL
.	NULL

To	NULL
further	NULL
elucidate	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
B	NULL
subunit	NULL
and	NULL
JAK2	NULL
we	NULL
performed	NULL
co-immunoprecipitation	NULL
experiments	NULL
in	NULL
unstimulated	NULL
and	NULL
GM-CSF-stimulated	NULL
PMN	NULL
.	NULL

The	NULL
results	NULL
,	NULL
reported	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
demonstrate	NULL
that	NULL
in	NULL
PMN	NULL
p130	NULL
JAK2	NULL
physically	NULL
associates	NULL
with	NULL
the	NULL
B	NULL
subunit	NULL
only	NULL
upon	NULL
GMCSF	NULL
stimulation	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
under	NULL
physiological	NULL
condi-tions	NULL
,	NULL
the	NULL
association	NULL
between	NULL
JAK2	NULL
and	NULL
the	NULL
receptor	NULL
may	NULL
not	NULL
be	NULL
constitutive	NULL
.	NULL

Kinetic	NULL
analysis	NULL
of	NULL
JAK2	NULL
activation	NULL
,	NULL
upon	NULL
GMCSF	NULL
stimulation	NULL
,	NULL
reported	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
demonstrates	NULL
a	NULL
transient	NULL
JAK2	NULL
tyrosine	NULL
phosphorylation	NULL
peaking	NULL
at	NULL
5	NULL
min	NULL
and	NULL
disappearing	NULL
after	NULL
10	NULL
min	NULL
.	NULL

A	NULL
likely	NULL
set	NULL
of	NULL
substrates	NULL
for	NULL
the	NULL
JAKs	NULL
is	NULL
the	NULL
family	NULL
of	NULL
latent	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
3564	NULL
Signaling	NULL
in	NULL
PMN	NULL
Functional	NULL
Activation	NULL
amser	NULL
-	NULL
+	NULL
+0	NULL
+0	NULL
Da	NULL
-	NULL
200	NULL
JAK2	NULL
-	NULL
e	NULL
08	NULL
__|	NULL
-	NULL
0	NULL
<	NULL
e	NULL
100	NULL
®	NULL
@	NULL
w	NULL
®	NULL
__	NULL
,	NULL
,	NULL
,	NULL
time	NULL
_-	NULL
0	NULL
5°	NULL
10°	NULL
30°	NULL
IP	NULL
[	NULL
_	NULL
anti	NULL
JAK2	NULL
18	NULL
[	NULL
~-	NULL
anti	NULL
P-yr	NULL
JAKD__	NULL
wae	NULL
cme	NULL
»	NULL
cae	NULL
a	NULL
IB	NULL
[	NULL
-_	NULL
anti	NULL
JAK2	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Kinetic	NULL
analysis	NULL
of	NULL
GM-CSF-induced	NULL
JAK2	NULL
activation	NULL
in	NULL
human	NULL
PMN	NULL
.	NULL

PMN	NULL
were	NULL
incubated	NULL
in	NULL
1640	NULL
RPMI	NULL
medium	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
anti-JAK2	NULL
antiserum	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
4G10	NULL
anti-phosphotyrosine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
reprobed	NULL
with	NULL
the	NULL
antiserum	NULL
against	NULL
JAK2	NULL
(	NULL
Fower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
p1830-JAK2	NULL
and	NULL
the	NULL
p90	NULL
phosphotyrosine	NULL
proteins	NULL
are	NULL
indicated	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitated	NULL
;	NULL
IB	NULL
,	NULL
immunoblotted	NULL
;	NULL
P-tyr	NULL
,	NULL
phosphotyrosine	NULL
.	NULL

A	NULL
B	NULL
kDa	NULL
kDa	NULL
GM-CSF	NULL
-	NULL
+	NULL
GM-CSF	NULL
-~	NULL
+	NULL
-	NULL
200	NULL
-	NULL
200	NULL
p130	NULL
--	NULL
par	NULL
-	NULL
__	NULL
dgk	NULL
-100	NULL
pastes	NULL
__	NULL
__	NULL
wa	NULL
-100	NULL
cate	NULL
__	NULL
..	NULL
,	NULL
«	NULL
»	NULL
_	NULL
...	NULL
.	NULL

IP	NULL
p	NULL
18	NULL
[	NULL
anti	NULL
P-tyr	NULL
81	NULL
P	NULL
p93	NULL
!	NULL

ES_	NULL
am	NULL
»	NULL
sual	NULL
IB	NULL
!	NULL

8	NULL
-	NULL
[	NULL
anti	NULL
paa'es	NULL
]	NULL
C	NULL
kDa	NULL
GM-CSF	NULL
-	NULL
+	NULL
-	NULL
200	NULL
-	NULL
46	NULL
IB	NULL
anti	NULL
p92	NULL
IP	NULL
p92	NULL
--	NULL
IB	NULL
-	NULL
|	NULL
anti	NULL
p92	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

GM-CSF-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT-p91	NULL
,	NULL
STATp92	NULL
,	NULL
and	NULL
p93	NULL
``	NULL
*	NULL
``	NULL
in	NULL
PMN	NULL
.	NULL

Untreated	NULL
(	NULL
-	NULL
)	NULL
and	NULL
GM-CSF-treated	NULL
(	NULL
for	NULL
5	NULL
min	NULL
with	NULL
10	NULL
ng/ml	NULL
of	NULL
GM-CSF	NULL
)	NULL
(	NULL
+	NULL
)	NULL
PMN	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-p91	NULL
(	NULL
4	NULL
)	NULL
anti-p93'*	NULL
``	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
anti-p92	NULL
(	NULL
C	NULL
)	NULL
antibodies	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
probed	NULL
with	NULL
4G10	NULL
anti-phosphotyrosine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
upper	NULL
panels	NULL
)	NULL
and	NULL
reprobed	NULL
with	NULL
anti-p91	NULL
(	NULL
A	NULL
)	NULL
,	NULL
anti-p93'*	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
anti-p91	NULL
(	NULL
C	NULL
)	NULL
antibodies	NULL
(	NULL
Lower	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
p91	NULL
,	NULL
p93	NULL
``	NULL
,	NULL
and	NULL
p92	NULL
are	NULL
indicated	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitated	NULL
;	NULL
IB	NULL
,	NULL
immunoblotted	NULL
;	NULL
P-tyr	NULL
,	NULL
phosphotyrosine	NULL
.	NULL

cytoplasmic	NULL
transcription	NULL
factors	NULL
termed	NULL
STATs	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Ligand	NULL
binding	NULL
to	NULL
several	NULL
cytokine	NULL
receptors	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
family	NULL
members	NULL
that	NULL
,	NULL
subsequently	NULL
,	NULL
translo-cate	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
bind	NULL
to	NULL
related	NULL
DNA	NULL
sequences	NULL
,	NULL
and	NULL
promote	NULL
transcription	NULL
(	NULL
39-52	NULL
)	NULL
.	NULL

The	NULL
anti-phosphotyrosine	NULL
blot	NULL
of	NULL
anti-JAK2	NULL
immunoprecipitates	NULL
from	NULL
GM-CSF-treated	NULL
PMN	NULL
re-vealed	NULL
,	NULL
together	NULL
with	NULL
the	NULL
phosphorylated	NULL
p130	NULL
JAK2	NULL
,	NULL
a	NULL
marked	NULL
A	NULL
B	NULL
kDa	NULL
am-cs3r	NULL
-	NULL
+	NULL
kDa	NULL
GM-CSF	NULL
-	NULL
+	NULL
--	NULL
200	NULL
-	NULL
200	NULL
p130	NULL
-	NULL
alee	NULL
|__	NULL
p	NULL
ao	NULL
-__	NULL
Wah	NULL
-1090	NULL
p91	NULL
-	NULL
-	NULL
``	NULL
@	NULL
ame	NULL
-~	NULL
***	NULL
_-	NULL
46	NULL
Pus	NULL
___	NULL
,	NULL
,	NULL
,	NULL
ip	NULL
_	NULL
[	NULL
anti	NULL
JAK2	NULL
IP	NULL
anti	NULL
[	NULL
JAK2	NULL
[	NULL
poi	NULL
]	NULL
is	NULL
is	NULL
--	NULL
J	NULL
kDa	NULL
kDa	NULL
GM-CSF	NULL
-	NULL
4	NULL
-	NULL
GM-CSF	NULL
-	NULL
+-r	NULL
‘	NULL
v_200	NULL
--	NULL
200	NULL
pos-	NULL
__	NULL
pastes	NULL
-100	NULL
«	NULL
<	NULL
_..	NULL
e	NULL
IP	NULL
anti	NULL
[	NULL
JAK	NULL
[	NULL
p92	NULL
]	NULL
IP	NULL
ant	NULL
[	NULL
JAK2	NULL
|p9s	NULL
]	NULL
1B	NULL
anti	NULL
paz	NULL
1B	NULL
Fic	NULL
.	NULL

4.	NULL
p91	NULL
,	NULL
p92	NULL
,	NULL
and	NULL
p93	NULL
``	NULL
are	NULL
physically	NULL
associated	NULL
with	NULL
JAK2	NULL
.	NULL

Unstimulated	NULL
(	NULL
-	NULL
)	NULL
and	NULL
GM-CSP-stimulated	NULL
(	NULL
+	NULL
)	NULL
PMN	NULL
were	NULL
lysed	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-JAK2	NULL
antiserum	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
divided	NULL
into	NULL
four	NULL
aliquots	NULL
that	NULL
were	NULL
resolved	NULL
in	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
blotted	NULL
independently	NULL
.	NULL

A	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
4G10	NULL
anti-phosphotyrosine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
reprobed	NULL
with	NULL
anti-JAK2	NULL
antiserum	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
anti-p91	NULL
antiserum	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
also	NULL
immunoprecipitated	NULL
with	NULL
anti-p91	NULL
antiserum	NULL
to	NULL
indicate	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
p91	NULL
protein	NULL
.	NULL

C	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
anti-p92	NULL
antibody	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
also	NULL
immunoprecipitated	NULL
with	NULL
anti-p92	NULL
antiserum	NULL
to	NULL
indicate	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
p92	NULL
protein	NULL
.	NULL

D	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
anti-p93'*	NULL
``	NULL
antiserum	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
also	NULL
immunoprecipitated	NULL
with	NULL
anti-p93'*	NULL
``	NULL
antiserum	NULL
to	NULL
indicate	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
p93**	NULL
protein	NULL
.	NULL

The	NULL
position	NULL
of	NULL
p91	NULL
,	NULL
p92	NULL
,	NULL
and	NULL
p93	NULL
``	NULL
are	NULL
indicated	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitated	NULL
;	NULL
IB	NULL
,	NULL
immunoblotted	NULL
;	NULL
P-tyr	NULL
,	NULL
phosphotyrosine	NULL
.	NULL

band	NULL
of	NULL
phosphotyrosine-containing	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
of	NULL
approximately	NULL
90	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
among	NULL
the	NULL
STAT	NULL
proteins	NULL
STAT1	NULL
and	NULL
STAT3	NULL
exhibit	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
91	NULL
and	NULL
92	NULL
kDa	NULL
,	NULL
respectively	NULL
.	NULL

Therefore	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
JAK2	NULL
co-precipitating	NULL
p90	NULL
phosphoprotein	NULL
(	NULL
s	NULL
)	NULL
included	NULL
one	NULL
or	NULL
both	NULL
STAT	NULL
's	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
that	NULL
a	NULL
p93	NULL
myeloid-specific	NULL
protein	NULL
,	NULL
the	NULL
product	NULL
of	NULL
the	NULL
protooncogene	NULL
c-fps/fes	NULL
,	NULL
becomes	NULL
phosphorylated	NULL
and	NULL
associated	NULL
to	NULL
the	NULL
GMCSF	NULL
receptor	NULL
B	NULL
common	NULL
subunit	NULL
upon	NULL
GM-CSF	NULL
stimulation	NULL
in	NULL
a	NULL
growth	NULL
factor-dependent	NULL
cell	NULL
line	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tried	NULL
to	NULL
assess	NULL
whether	NULL
p93°	NULL
``	NULL
was	NULL
also	NULL
included	NULL
in	NULL
JAK2	NULL
co-precipitating	NULL
p90	NULL
phosphoprotein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

To	NULL
test	NULL
these	NULL
possibilities	NULL
we	NULL
first	NULL
evaluated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p91	NULL
,	NULL
p92	NULL
,	NULL
and	NULL
p93	NULL
``	NULL
upon	NULL
GM-CSF	NULL
stimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
both	NULL
STAT	NULL
proteins	NULL
,	NULL
p91	NULL
and	NULL
p92	NULL
,	NULL
and	NULL
p93/**	NULL
become	NULL
phosphorylated	NULL
after	NULL
5	NULL
min	NULL
of	NULL
GM-CSF	NULL
treatment	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
the	NULL
anti-p91	NULL
and	NULL
-p92	NULL
immunoprecipitates	NULL
together	NULL
with	NULL
the	NULL
marked	NULL
band	NULL
of	NULL
approximately	NULL
90	NULL
kDa	NULL
a	NULL
faint	NULL
band	NULL
of	NULL
approximately	NULL
130	NULL
kDa	NULL
was	NULL
detected	NULL
.	NULL

Taken	NULL
together	NULL
these	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
at	NULL
least	NULL
the	NULL
two	NULL
STAT	NULL
proteins	NULL
physically	NULL
associated	NULL
with	NULL
JAK2	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
hypothesis	NULL
,	NULL
anti-JAK2	NULL
co-immunopre-cipitates	NULL
from	NULL
unstimulated	NULL
and	NULL
GM-CSF-stimulated	NULL
PMN	NULL
were	NULL
divided	NULL
into	NULL
four	NULL
aliquots	NULL
,	NULL
resolved	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
independently	NULL
blotted	NULL
with	NULL
the	NULL
antibodies	NULL
of	NULL
interest	NULL
.	NULL

In	NULL
the	NULL
anti-phosphotyrosine	NULL
immunoblot	NULL
reported	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
a	NULL
large	NULL
band	NULL
of	NULL
approximately	NULL
90	NULL
kDa	NULL
can	NULL
be	NULL
detected	NULL
only	NULL
in	NULL
GM-CSF-stimulated	NULL
PMN	NULL
.	NULL

The	NULL
anti-p91	NULL
,	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Signaling	NULL
in	NULL
PMN	NULL
Functional	NULL
Activation	NULL
3565	NULL
emosr	NULL
-	NULL
-	NULL
£0	NULL
kDa	NULL
-g	NULL
00	NULL
-	NULL
4+	NULL
--	NULL
200	NULL
p130	NULL
.l°0pgo	NULL
s	NULL
wo	NULL
tug	NULL
--	NULL
46	NULL
IP	NULL
[	NULL
anti	NULL
JAK2	NULL
1B	NULL
[	NULL
ant	NULL
Plyr	NULL
loos	NULL
tual	NULL
+	NULL
-p130	NULL
1B	NULL
[	NULL
anti	NULL
JAK2	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

GM-CSF-induced	NULL
JAK2	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
human	NULL
PMN	NULL
.	NULL

Cell	NULL
lysates	NULL
from	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
and	NULL
IL-3-	NULL
and	NULL
GM-CSF-stimulated	NULL
(	NULL
10	NULL
ng/ml	NULL
each	NULL
for	NULL
5	NULL
min	NULL
)	NULL
(	NULL
+	NULL
)	NULL
PMN	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-JAK2	NULL
antiserum	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
4G1O	NULL
anti-phosphotyrosine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
reprobed	NULL
with	NULL
the	NULL
antiserum	NULL
against	NULL
JAK2	NULL
(	NULL
ower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
p130-JAK2	NULL
and	NULL
the	NULL
p90	NULL
phosphotyrosine	NULL
proteins	NULL
are	NULL
indicated	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitated	NULL
;	NULL
IB	NULL
,	NULL
immunoblotted	NULL
;	NULL
P-tyr	NULL
,	NULL
phosphotyrosine	NULL
.	NULL

A	NULL
B	NULL
kDa	NULL
po-	NULL
+	NULL
kDa	NULL
GM-CS	NULL
_-	NULL
200	NULL
GMCSF	NULL
-	NULL
+	NULL
--	NULL
200	NULL
--	NULL
100	NULL
p90	NULL
--	NULL
-	NULL
/-p91	NULL
--	NULL
100	NULL
--	NULL
46	NULL
-	NULL
46	NULL
ip	NULL
anti	NULL
beta	NULL
IP	NULL
anti	NULL
[	NULL
bata	NULL
[	NULL
p91	NULL
]	NULL
18	NULL
[	NULL
ant	NULL
PAyr	NULL
18	NULL
[	NULL
anti	NULL
pgi	NULL
]	NULL
bota	NULL
--	NULL
a	NULL
.	NULL

%	NULL
wm	NULL
»	NULL
1B	NULL
R	NULL
kDa	NULL
kDa	NULL
GM-CSF	NULL
-	NULL
-	NULL
oe	NULL
_	NULL
200	NULL
GM-CSF	NULL
-	NULL
200	NULL
pga	NULL
--	NULL
-106	NULL
pastes	NULL
_	NULL
-100	NULL
-	NULL
46	NULL
-	NULL
45	NULL
IP	NULL
anti	NULL
[	NULL
beta	NULL
[	NULL
p92	NULL
]	NULL
IP	NULL
anti	NULL
[	NULL
beta	NULL
[	NULL
p93	NULL
]	NULL
1B	NULL
G	NULL
|	NULL
anti	NULL
pastes	NULL
Fic	NULL
.	NULL

6.	NULL
p91	NULL
,	NULL
p92	NULL
,	NULL
and	NULL
p98	NULL
'	NULL
``	NULL
``	NULL
physically	NULL
associate	NULL
with	NULL
the	NULL
GMCSF	NULL
receptor	NULL
6	NULL
common	NULL
subunit	NULL
.	NULL

Unstimulated	NULL
(	NULL
-	NULL
)	NULL
and	NULL
GM-CSF-stimulated	NULL
(	NULL
+	NULL
)	NULL
PMN	NULL
were	NULL
lysed	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-GM-CSF	NULL
receptor	NULL
B	NULL
common	NULL
subunit	NULL
antiserum	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
divided	NULL
into	NULL
four	NULL
aliquots	NULL
that	NULL
were	NULL
resolved	NULL
in	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
blotted	NULL
independently	NULL
.	NULL

A	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
4G10	NULL
anti-phosphotyrosine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
reprobed	NULL
with	NULL
anti-GM-CSF	NULL
receptor	NULL
B	NULL
common	NULL
subunit	NULL
antiserum	NULL
(	NULL
fower	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
anti-p91	NULL
antiserum	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
also	NULL
immunoprecipitated	NULL
with	NULL
anti-p91	NULL
antiserum	NULL
to	NULL
indicate	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
p91	NULL
protein	NULL
.	NULL

C	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
anti-p92	NULL
antibody	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
also	NULL
immunoprecipitated	NULL
with	NULL
anti-p92	NULL
antiserum	NULL
to	NULL
indicate	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
p92	NULL
protein	NULL
.	NULL

D	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
probed	NULL
with	NULL
anti-p93	NULL
``	NULL
antiserum	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
also	NULL
immunoprecipitated	NULL
with	NULL
anti-p93	NULL
``	NULL
antiserum	NULL
to	NULL
indicate	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
p93	NULL
``	NULL
protein	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
p91	NULL
,	NULL
p92	NULL
,	NULL
and	NULL
are	NULL
indicated	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitated	NULL
;	NULL
IB	NULL
,	NULL
immunoblotted	NULL
;	NULL
P-tyr	NULL
,	NULL
phosphotyrosine	NULL
.	NULL

anti-p92	NULL
,	NULL
and	NULL
anti-p93®	NULL
``	NULL
immunoblots	NULL
of	NULL
anti-JAK2	NULL
immunoprecipitates	NULL
from	NULL
untreated	NULL
and	NULL
GM-CSF-treated	NULL
PMN	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
B	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
,	NULL
respectively	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
two	NULL
STAT	NULL
proteins	NULL
together	NULL
with	NULL
the	NULL
p9	NULL
%	NULL
``	NULL
®	NULL
are	NULL
physically	NULL
associated	NULL
with	NULL
JAK2	NULL
only	NULL
upon	NULL
GM-CSF	NULL
stimulation	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
these	NULL
results	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
the	NULL
inabil-	NULL
A	NULL
B	NULL
_	NULL
kDa	NULL
kDa	NULL
Gltfs	NULL
'	NULL
:	NULL
I	NULL
L	NULL
*+	NULL
GM-CSF	NULL
-	NULL
-	NULL
+	NULL
-	NULL
200	NULL
IL-3	NULL
-	NULL
g	NULL
o_	NULL
-200	NULL
p130	NULL
-100	NULL
102,393	NULL
!	NULL

“	NULL
«	NULL
g	NULL
IP	NULL
_	NULL
[	NULL
anti	NULL
JAK2	NULL
IP	NULL
-p130	NULL
hame	NULL
-pastes	NULL
IP	NULL
_	NULL
[	NULL
anti	NULL
]	NULL
IP	NULL
[	NULL
anti	NULL
pggfes	NULL
IB	NULL
-	NULL
|	NULL
anti	NULL
JAK2	NULL
IB	NULL
|	NULL
anti	NULL
pg3fes	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

In	NULL
vitro	NULL
JAK2	NULL
and	NULL
p93	NULL
``	NULL
kinase	NULL
activity	NULL
following	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
stimulation	NULL
in	NULL
human	NULL
PMN	NULL
.	NULL

Anti-JAK2	NULL
(	NULL
panel	NULL
!	NULL

A	NULL
)	NULL
and	NULL
anti-p93	NULL
``	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
immunoprecipitates	NULL
from	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
and	NULL
IL-3-	NULL
and	NULL
GM-CSF-stimulated	NULL
(	NULL
10	NULL
ng/ml	NULL
each	NULL
for	NULL
5	NULL
min	NULL
)	NULL
(	NULL
+	NULL
)	NULL
PMN	NULL
were	NULL
washed	NULL
and	NULL
divided	NULL
in	NULL
two	NULL
aliquots	NULL
.	NULL

The	NULL
first	NULL
one	NULL
was	NULL
resuspended	NULL
in	NULL
the	NULL
kinase	NULL
assay	NULL
buffer	NULL
containing	NULL
[	NULL
y-*°P	NULL
]	NULL
JATP	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
washed	NULL
and	NULL
eluted	NULL
with	NULL
sample	NULL
buffer	NULL
for	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
separated	NULL
on	NULL
8	NULL
%	NULL
gel	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
auto-radiography	NULL
(	NULL
upper	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
second	NULL
one	NULL
was	NULL
separated	NULL
on	NULL
8	NULL
%	NULL
gel	NULL
and	NULL
probed	NULL
with	NULL
anti-JAK2	NULL
and	NULL
anti-p93	NULL
``	NULL
*	NULL
``	NULL
antisera	NULL
,	NULL
respectively	NULL
(	NULL
Lower	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
p130-JAK2	NULL
and	NULL
the	NULL
p9®*	NULL
proteins	NULL
are	NULL
indicated	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitated	NULL
;	NULL
IB	NULL
,	NULL
immunoblotted	NULL
.	NULL

ity	NULL
of	NULL
anti-JAK1	NULL
antiserum	NULL
to	NULL
co-immunoprecipitate	NULL
these	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
the	NULL
correlation	NULL
between	NULL
the	NULL
biochemical	NULL
events	NULL
induced	NULL
by	NULL
GM-CSF	NULL
stimulation	NULL
and	NULL
its	NULL
biological	NULL
effects	NULL
on	NULL
PMN	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
,	NULL
upon	NULL
IL-3	NULL
stimulation	NULL
,	NULL
neither	NULL
functional	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
or	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
were	NULL
detected	NULL
in	NULL
anti-JAK2	NULL
immunoprecipitates	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
JAK2	NULL
physically	NULL
associates	NULL
with	NULL
the	NULL
8	NULL
common	NULL
subunit	NULL
as	NULL
well	NULL
as	NULL
with	NULL
p91	NULL
and	NULL
p92	NULL
STATs	NULL
and	NULL
p9	NULL
%	NULL
¥®	NULL
``	NULL
implies	NULL
that	NULL
the	NULL
latter	NULL
three	NULL
proteins	NULL
are	NULL
also	NULL
directly	NULL
or	NULL
indirectly	NULL
,	NULL
via	NULL
JAK2	NULL
,	NULL
associated	NULL
with	NULL
the	NULL
B	NULL
common	NULL
.	NULL

To	NULL
evaluate	NULL
this	NULL
hypothesis	NULL
anti-beta	NULL
co-immunoprecipitation	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
anti-phosphotyrosine	NULL
immunoblot	NULL
of	NULL
anti-§	NULL
common	NULL
immunoprecipitates	NULL
from	NULL
unstimulated	NULL
and	NULL
GM-CSF-stimulated	NULL
PMN	NULL
,	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
demonstrates	NULL
the	NULL
presence	NULL
of	NULL
approximately	NULL
90-kDa	NULL
tyrosine-phosphorylated	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
only	NULL
in	NULL
GM-CSF-stimulated	NULL
cells	NULL
.	NULL

Moreover	NULL
when	NULL
aliquots	NULL
of	NULL
the	NULL
same	NULL
samples	NULL
were	NULL
resolved	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
independently	NULL
blotted	NULL
with	NULL
the	NULL
anti-p91	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
anti-p92	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
,	NULL
and	NULL
anti-p93	NULL
%	NULL
®®	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
antibodies	NULL
,	NULL
the	NULL
two	NULL
STAT	NULL
proteins	NULL
together	NULL
with	NULL
the	NULL
were	NULL
found	NULL
to	NULL
be	NULL
physically	NULL
associated	NULL
,	NULL
upon	NULL
ligand	NULL
binding	NULL
,	NULL
with	NULL
the	NULL
B	NULL
common	NULL
subunit	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
various	NULL
tyrosine	NULL
kinases	NULL
is	NULL
commonly	NULL
associated	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
their	NULL
catalytic	NULL
activity	NULL
(	NULL
53	NULL
)	NULL
.	NULL

An	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
was	NULL
performed	NULL
to	NULL
examine	NULL
whether	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
and	NULL
p93/*®	NULL
correlates	NULL
with	NULL
their	NULL
intrinsic	NULL
kinase	NULL
activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
anti-JAK2	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
and	NULL
anti-p93'®®	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
immunoprecipitates	NULL
from	NULL
GM-CSF-stimulated	NULL
,	NULL
but	NULL
not	NULL
from	NULL
IL-3-stimulated	NULL
,	NULL
PMN	NULL
have	NULL
a	NULL
detectable	NULL
in	NULL
vitro	NULL
kinase	NULL
activity	NULL
.	NULL

PMN	NULL
are	NULL
terminally	NULL
differentiated	NULL
cells	NULL
and	NULL
do	NULL
not	NULL
undergo	NULL
proliferation	NULL
;	NULL
however	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
intracellular	NULL
substrates	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
a	NULL
number	NULL
of	NULL
functional	NULL
activities	NULL
such	NULL
as	NULL
superoxide	NULL
anion	NULL
production	NULL
(	NULL
54-58	NULL
)	NULL
;	NULL
regulation	NULL
of	NULL
integrin	NULL
surface	NULL
expression	NULL
,	NULL
leading	NULL
to	NULL
adherence	NULL
of	NULL
PMN	NULL
to	NULL
endothelial	NULL
cells	NULL
(	NULL
59	NULL
)	NULL
;	NULL
regulation	NULL
of	NULL
microvascular	NULL
per-meability	NULL
,	NULL
leading	NULL
to	NULL
migration	NULL
of	NULL
PMN	NULL
into	NULL
inflammatory	NULL
tissue	NULL
(	NULL
60	NULL
,	NULL
61	NULL
)	NULL
;	NULL
and	NULL
modulation	NULL
of	NULL
apoptotic	NULL
process	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
physiological	NULL
agonist-mediated	NULL
or	NULL
GM-CSF-mediated	NULL
PMN	NULL
activation	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
PMN	NULL
biological	NULL
responses	NULL
are	NULL
prevented	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
(	NULL
15	NULL
,	NULL
55	NULL
,	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
3566	NULL
Signaling	NULL
in	NULL
PMN	NULL
Functional	NULL
Activation	NULL
A	NULL
B	NULL
Competitor	NULL
-	NULL
-	NULL
4	NULL
+	NULL
HEPG2	NULL
P	NULL
M	NULL
N	NULL
mt	NULL
im	NULL
-	NULL
--	NULL
--	NULL
--	NULL
43	NULL
PI	NULL
pS2	NULL
PL	NULL
PI	NULL
PI	NULL
p92	NULL
-	NULL
®	NULL
<	NULL
--	NULL
»	NULL
a-	NULL
#	NULL
q	NULL
=p	NULL
J	NULL
!	NULL

‘	NULL
A	NULL
)	NULL
&	NULL
08	NULL
i.	NULL
ad	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

A	NULL
,	NULL
induction	NULL
of	NULL
DNA-binding	NULL
activity	NULL
by	NULL
GM-CSF	NULL
and	NULL
IL-6	NULL
in	NULL
PMN	NULL
and	NULL
in	NULL
HEPG2	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
15-min	NULL
IL-6-treated	NULL
HEPG2	NULL
cells	NULL
and	NULL
GM-CSF-treated	NULL
PMN	NULL
(	NULL
+	NULL
)	NULL
were	NULL
either	NULL
treated	NULL
(	NULL
+	NULL
)	NULL
or	NULL
not	NULL
(	NULL
-	NULL
)	NULL
treated	NULL
with	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
competitor	NULL
)	NULL
for	NULL
30	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
radiolabeled	NULL
oligonucleotide	NULL
.	NULL

The	NULL
complexes	NULL
were	NULL
then	NULL
resolved	NULL
by	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
DNA-binding	NULL
complexes	NULL
are	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
the	NULL
GM-CSF-induced	NULL
DNA-binding	NULL
complex	NULL
is	NULL
antigeni-cally	NULL
related	NULL
to	NULL
p91	NULL
and	NULL
p92	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
15-min	NULL
GM-CSF-treated	NULL
PMN	NULL
or	NULL
IL-6-treated	NULL
HEPG2	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
preimmune	NULL
serum	NULL
(	NULL
P7	NULL
)	NULL
,	NULL
anti-p91	NULL
antiserum	NULL
,	NULL
or	NULL
anti-p92	NULL
antibodies	NULL
before	NULL
incubation	NULL
with	NULL
radiolabeled	NULL
oligonucleotide	NULL
and	NULL
separated	NULL
on	NULL
a	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
IL-6-and	NULL
GM-CSF-induced	NULL
DNA-protein	NULL
complexes	NULL
and	NULL
the	NULL
supershifted	NULL
specie	NULL
are	NULL
indicated	NULL
.	NULL

56	NULL
,	NULL
59	NULL
,	NULL
62	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
,	NULL
in	NULL
PMN	NULL
,	NULL
GM-CSF	NULL
causes	NULL
a	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
intracellular	NULL
molecules	NULL
including	NULL
both	NULL
90-	NULL
and	NULL
130-kDa	NULL
proteins	NULL
(	NULL
15	NULL
,	NULL
55	NULL
,	NULL
62	NULL
,	NULL
63	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
these	NULL
findings	NULL
,	NULL
the	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
a	NULL
set	NULL
of	NULL
90-kDa	NULL
proteins	NULL
namely	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
p93	NULL
and	NULL
a	NULL
130-kDa	NULL
protein	NULL
,	NULL
identified	NULL
as	NULL
JAK2	NULL
,	NULL
become	NULL
phosphorylated	NULL
upon	NULL
GM-CSF	NULL
stimulation	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
reasonable	NULL
to	NULL
assume	NULL
that	NULL
at	NULL
least	NULL
some	NULL
PMN	NULL
functional	NULL
activities	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
the	NULL
JAK/STAT	NULL
signaling	NULL
pathway	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
different	NULL
cytokines	NULL
results	NULL
in	NULL
rapid	NULL
STAT	NULL
protein	NULL
phosphorylation	NULL
.	NULL

Activated	NULL
STATs	NULL
(	NULL
one	NULL
or	NULL
more	NULL
)	NULL
form	NULL
dimers	NULL
that	NULL
migrate	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
form	NULL
stable	NULL
complexes	NULL
with	NULL
specific	NULL
DNA	NULL
sequences	NULL
(	NULL
response	NULL
elements	NULL
)	NULL
and	NULL
stimulate	NULL
transcription	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Three	NULL
discrete	NULL
complexes	NULL
between	NULL
activated	NULL
STAT	NULL
proteins	NULL
and	NULL
DNA	NULL
response	NULL
elements	NULL
have	NULL
been	NULL
demonstrated	NULL
upon	NULL
EGF	NULL
treatment	NULL
(	NULL
50	NULL
)	NULL
.	NULL

These	NULL
complexes	NULL
seem	NULL
to	NULL
be	NULL
formed	NULL
by	NULL
STAT1	NULL
or	NULL
STAT3	NULL
homodimers	NULL
or	NULL
by	NULL
heterodimers	NULL
between	NULL
the	NULL
two	NULL
STATs	NULL
(	NULL
50	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
interferon-y-	NULL
(	NULL
44	NULL
)	NULL
,	NULL
IL-6-	NULL
(	NULL
50	NULL
)	NULL
,	NULL
and	NULL
GM-CSF-treated	NULL
cells	NULL
(	NULL
51	NULL
)	NULL
,	NULL
only	NULL
one	NULL
complex	NULL
can	NULL
be	NULL
detected	NULL
containing	NULL
either	NULL
the	NULL
STAT1	NULL
(	NULL
45	NULL
)	NULL
or	NULL
the	NULL
STAT3	NULL
homodimers	NULL
(	NULL
51	NULL
)	NULL
.	NULL

The	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p91	NULL
and	NULL
p92	NULL
observed	NULL
in	NULL
GM-CSF-stimulated	NULL
PMN	NULL
led	NULL
us	NULL
to	NULL
evaluate	NULL
,	NULL
by	NULL
gel	NULL
retardation	NULL
assay	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
in	NULL
nuclear	NULL
extract	NULL
of	NULL
untreated	NULL
and	NULL
treated	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
both	NULL
in	NULL
IL-6-treated	NULL
HEPG2	NULL
cells	NULL
and	NULL
in	NULL
GM-CSF-treated	NULL
PMN	NULL
a	NULL
DNA-protein	NULL
complex	NULL
appears	NULL
.	NULL

Moreover	NULL
when	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
,	NULL
both	NULL
the	NULL
IL-6-	NULL
and	NULL
GM-CSF	NULL
-induced	NULL
complexes	NULL
are	NULL
competed	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
demonstrating	NULL
its	NULL
sequence	NULL
specificity	NULL
.	NULL

Moreover	NULL
it	NULL
is	NULL
also	NULL
clear	NULL
that	NULL
the	NULL
DNA-binding	NULL
complex	NULL
observed	NULL
in	NULL
IL-6-stimulated	NULL
HEPG2	NULL
cells	NULL
shows	NULL
a	NULL
slower	NULL
migration	NULL
than	NULL
that	NULL
observed	NULL
in	NULL
GM-CSF-stimulated	NULL
PMN	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
in	NULL
HEPG2	NULL
cells	NULL
IL-6	NULL
induces	NULL
only	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
major	NULL
complex	NULL
,	NULL
defined	NULL
also	NULL
as	NULL
SIF-A	NULL
(	NULL
40	NULL
,	NULL
45	NULL
)	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
complex	NULL
containing	NULL
p92	NULL
homodimers	NULL
(	NULL
50	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
EGF-activated	NULL
proteins	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
form	NULL
three	NULL
complexes	NULL
,	NULL
designated	NULL
as	NULL
SIF-A	NULL
,	NULL
SIF-B	NULL
,	NULL
and	NULL
SIF-C	NULL
(	NULL
50	NULL
)	NULL
,	NULL
with	NULL
the	NULL
serum-inducible	NULL
element	NULL
of	NULL
c-fos	NULL
(	NULL
in	NULL
its	NULL
mutated	NULL
,	NULL
hyperactive	NULL
form	NULL
)	NULL
(	NULL
40	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
faster	NULL
migrating	NULL
complex	NULL
observed	NULL
in	NULL
GM-CSF-stimulated	NULL
PMN	NULL
contains	NULL
either	NULL
STATI-STAT3	NULL
heterodimers	NULL
and/or	NULL
STAT1	NULL
homodimers	NULL
.	NULL

We	NULL
thus	NULL
tested	NULL
the	NULL
GM-CSF-induced	NULL
complex	NULL
for	NULL
reactivity	NULL
with	NULL
anti-STAT1	NULL
p91	NULL
and	NULL
anti-STAT3	NULL
p92	NULL
antibodies	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
when	NULL
anti-p91	NULL
and	NULL
anti-p92	NULL
antisera	NULL
were	NULL
added	NULL
to	NULL
GM-CSF	NULL
-treated	NULL
nuclear	NULL
extract	NULL
,	NULL
a	NULL
new	NULL
band	NULL
,	NULL
which	NULL
was	NULL
not	NULL
present	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
with	NULL
preimmune	NULL
serum	NULL
,	NULL
appeared	NULL
in	NULL
the	NULL
upper	NULL
part	NULL
of	NULL
the	NULL
gel	NULL
,	NULL
thus	NULL
demonstrating	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
supershifted	NULL
species	NULL
.	NULL

A	NULL
supershifted	NULL
species	NULL
appears	NULL
also	NULL
when	NULL
nuclear	NULL
extract	NULL
from	NULL
IL-6-stimulated	NULL
HEPG2	NULL
cells	NULL
was	NULL
preincubated	NULL
with	NULL
anti-p92	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
The	NULL
presence	NULL
of	NULL
the	NULL
supershifted	NULL
complex	NULL
observed	NULL
both	NULL
in	NULL
anti-p91	NULL
and	NULL
anti-p92-pretreated	NULL
nuclear	NULL
extract	NULL
suggests	NULL
that	NULL
,	NULL
in	NULL
PMN	NULL
,	NULL
GM-CSF	NULL
can	NULL
rapidly	NULL
modulate	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
DNA-binding	NULL
complex	NULL
containing	NULL
p91	NULL
and	NULL
p92	NULL
heterodimer	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
GM-CSF-mediated	NULL
PMN	NULL
functional	NULL
activation	NULL
and	NULL
c-fos	NULL
gene	NULL
transcription	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Moreover	NULL
the	NULL
role	NULL
of	NULL
tyrosine	NULL
kinases	NULL
in	NULL
controlling	NULL
GM-CSF-induced	NULL
c-fos	NULL
gene	NULL
expression	NULL
in	NULL
PMN	NULL
,	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
the	NULL
use	NULL
of	NULL
a	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
at	NULL
least	NULL
two	NULL
of	NULL
the	NULL
STAT	NULL
proteins	NULL
that	NULL
become	NULL
phosphorylated	NULL
upon	NULL
GM-CSF	NULL
stimulation	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
complex	NULL
with	NULL
the	NULL
serum-inducible	NULL
elements	NULL
of	NULL
c-fos	NULL
,	NULL
supports	NULL
the	NULL
hypothesis	NULL
that	NULL
GMCSF	NULL
can	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
this	NULL
gene	NULL
via	NULL
STAT1	NULL
and	NULL
STAT3	NULL
activation	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
study	NULL
demonstrates	NULL
that	NULL
in	NULL
PMN	NULL
both	NULL
STAT1	NULL
p91	NULL
and	NULL
STAT3	NULL
p92	NULL
and	NULL
the	NULL
myeloid-specific	NULL
p93/*	NULL
become	NULL
phosphorylated	NULL
upon	NULL
GM-CSF	NULL
stimulation	NULL
and	NULL
are	NULL
co-immunoprecipitated	NULL
by	NULL
anti-JAK2	NULL
and	NULL
anti-B	NULL
common	NULL
subunit	NULL
antibodies	NULL
,	NULL
and	NULL
that	NULL
GM-CSF	NULL
induces	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
DNA-protein	NULL
complex	NULL
containing	NULL
both	NULL
p91	NULL
and	NULL
p92	NULL
.	NULL

The	NULL
redundancy	NULL
of	NULL
growth	NULL
factors	NULL
inducing	NULL
the	NULL
same	NULL
DNA-responsive	NULL
element	NULL
to	NULL
stimulate	NULL
both	NULL
cell	NULL
proliferation	NULL
and	NULL
functional	NULL
activation	NULL
raises	NULL
the	NULL
question	NULL
of	NULL
how	NULL
their	NULL
specificity	NULL
can	NULL
be	NULL
determined	NULL
.	NULL

The	NULL
answer	NULL
could	NULL
be	NULL
obtained	NULL
by	NULL
the	NULL
identification	NULL
of	NULL
more	NULL
genes	NULL
whose	NULL
transcription	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
known	NULL
or	NULL
unknown	NULL
proteins	NULL
.	NULL

Acknowledgment-We	NULL
thank	NULL
Prof.	NULL
G.	NULL
Borreani	NULL
for	NULL
carefully	NULL
reading	NULL
this	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Clark	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
Kamen	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
286	NULL
,	NULL
1229-1237	NULL
2	NULL
.	NULL

Weisbart	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

187	NULL
,	NULL
3584-3587	NULL
3	NULL
.	NULL

Lopez	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Williamson	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Gamble	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Harlan	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Klebanoff	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Waltersdorpf	NULL
,	NULL
A.	NULL
,	NULL
Wong	NULL
,	NULL
G.	NULL
,	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
Vadas	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

78	NULL
,	NULL
1220-1228	NULL
4	NULL
.	NULL

Socinski	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Cannistra	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Sullivan	NULL
,	NULL
R.	NULL
,	NULL
Elias	NULL
,	NULL
A.	NULL
,	NULL
Antman	NULL
,	NULL
K.	NULL
,	NULL
Schnipper	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Griffin	NULL
.	NULL

J.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Blood	NULL
72	NULL
,	NULL
691-697	NULL
5	NULL
.	NULL

Arnaout	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Wang	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
Sieff	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

78	NULL
,	NULL
597-601	NULL
6	NULL
.	NULL

Nathan	NULL
,	NULL
C.	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
73	NULL
,	NULL
301-306	NULL
7	NULL
.	NULL

Nathan	NULL
,	NULL
C.	NULL
,	NULL
Srimal	NULL
,	NULL
S.	NULL
,	NULL
Farber	NULL
,	NULL
C.	NULL
,	NULL
Sanchez	NULL
,	NULL
E.	NULL
,	NULL
Kabbash	NULL
,	NULL
L.	NULL
,	NULL
Asch	NULL
,	NULL
A.	NULL
,	NULL
Gailit	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

109	NULL
,	NULL
1341-1349	NULL
8	NULL
.	NULL

Fleischmann	NULL
,	NULL
J.	NULL
,	NULL
Golde	NULL
,	NULL
D.	NULL
,	NULL
Wiesbart	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Blood	NULL
68	NULL
,	NULL
708-711	NULL
9	NULL
.	NULL

Naccache	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Faucher	NULL
,	NULL
N.	NULL
,	NULL
Borgeat	NULL
,	NULL
P.	NULL
,	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
DiPersio	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
3541-3546	NULL
10	NULL
.	NULL

McColl	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Beauseigle	NULL
,	NULL
D.	NULL
,	NULL
Gilbert	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Naccache	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

145	NULL
,	NULL
3047-8053	NULL
11	NULL
.	NULL

Wirthmueller	NULL
,	NULL
U.	NULL
,	NULL
De	NULL
Wick	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Dahinden	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

Signaling	NULL
in	NULL
PMN	NULL
Functional	NULL
Activation	NULL
3213-3218	NULL
DiPersio	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Billing	NULL
,	NULL
P.	NULL
,	NULL
Williams	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
4315-4322	NULL
McColl	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Krump	NULL
,	NULL
E.	NULL
,	NULL
Naccache	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Poubelle	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
Braquet	NULL
,	NULL
P.	NULL
,	NULL
Braquet	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Borgeat	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
1204-1211	NULL
Dahinden	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Zingg	NULL
,	NULL
J.	NULL
,	NULL
Maly	NULL
,	NULL
F.	NULL
E.	NULL
,	NULL
and	NULL
de	NULL
Weck	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167	NULL
,	NULL
1281-1295	NULL
Yousefi	NULL
,	NULL
S.	NULL
,	NULL
Green	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Blaser	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Simon	NULL
,	NULL
H-U	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
10868-10872	NULL
Gearing	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
King	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Gough	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
Nicola	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
3667-3676	NULL
Hayashida	NULL
,	NULL
K.	NULL
,	NULL
Kitamura	NULL
.	NULL

T.	NULL
,	NULL
Gorman	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9655-9659	NULL
Tavernier	NULL
,	NULL
J.	NULL
,	NULL
Devos	NULL
,	NULL
R.	NULL
,	NULL
Cornelis	NULL
,	NULL
S.	NULL
,	NULL
Tuypens	NULL
,	NULL
T.	NULL
,	NULL
Van	NULL
der	NULL
Heyden	NULL
,	NULL
J.	NULL
,	NULL
Fiers	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Plactinck	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
1175-1184	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Akira	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
253-262	NULL
Lanfrancone	NULL
,	NULL
L.	NULL
,	NULL
Pelicci	NULL
,	NULL
G.	NULL
,	NULL
Brizzi	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Aronica	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Casciari	NULL
,	NULL
C.	NULL
,	NULL
Giuli	NULL
,	NULL
S.	NULL
,	NULL
Pegoraro	NULL
,	NULL
L.	NULL
,	NULL
Pawson	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Pelicci	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
10	NULL
,	NULL
907-917	NULL
Lowenstein	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Daly	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Batzer	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Li	NULL
,	NULL
W.	NULL
,	NULL
Margolis	NULL
,	NULL
B.	NULL
,	NULL
Lammers	NULL
,	NULL
R.	NULL
,	NULL
Ullrich	NULL
,	NULL
A.	NULL
,	NULL
Skolnik	NULL
,	NULL
E.	NULL
Y.	NULL
,	NULL
Bar-Sagi	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Schlessinger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
431-442	NULL
Cutler	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Liu	NULL
,	NULL
L.	NULL
,	NULL
Damen	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Krystal	NULL
,	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
21463-21465	NULL
Satoh	NULL
,	NULL
T.	NULL
,	NULL
Nakafuku	NULL
,	NULL
M.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kaziro	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
3314-3318	NULL
Carroll	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Clark-Lewis	NULL
,	NULL
I.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
,	NULL
and	NULL
May	NULL
,	NULL
W.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
19812-19817	NULL
Okuda	NULL
,	NULL
K.	NULL
,	NULL
Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Pelech	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Kanakura	NULL
,	NULL
Y.	NULL
,	NULL
Hallek	NULL
,	NULL
M.	NULL
,	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Druker	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
2880-2887	NULL
Hanazono	NULL
,	NULL
Y.	NULL
,	NULL
Chiba	NULL
,	NULL
Y.	NULL
,	NULL
Sasaki	NULL
,	NULL
K.	NULL
,	NULL
Mano	NULL
,	NULL
H.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
Yazaki	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Hirai	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
1641-1646	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Kurban	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Ralph	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Zurcher	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Ziemiecki	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2057-2065	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Andres	NULL
,	NULL
A.	NULL
,	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
,	NULL
Aston	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
(	NULL
1992	NULL
)	NULL
Oncogene	NULL
4	NULL
,	NULL
1347-1353	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Sato	NULL
,	NULL
N.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Inhorn	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Eder	NULL
,	NULL
M.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
4335-4341	NULL
Brizzi	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Zini	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Aronica	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Blechman	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Yarden	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Pegoraro	NULL
,	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
31680-31684	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Prezioso	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
809-813	NULL
Muller	NULL
,	NULL
M.	NULL
,	NULL
Briscoe	NULL
,	NULL
J.	NULL
,	NULL
Laxton	NULL
,	NULL
C.	NULL
,	NULL
Guschin	NULL
,	NULL
D.	NULL
,	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Barbieri	NULL
,	NULL
G.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Pellegrini	NULL
,	NULL
S.	NULL
,	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
hle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
866	NULL
,	NULL
129-135	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Schlessinger	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
366	NULL
,	NULL
583-585	NULL
Watling	NULL
,	NULL
D.	NULL
,	NULL
Guschin	NULL
,	NULL
D.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Rogers	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Schindler	NULL
,	NULL
C	NULL
,	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Thie	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Kerr	NULL
,	NULL
L.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
366	NULL
,	NULL
166-170	NULL
Miura	NULL
,	NULL
O.	NULL
,	NULL
Nakamura	NULL
,	NULL
N.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Ihle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Aoki	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
1501-1507	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

3567	NULL
Pales	NULL
,	NULL
E.	NULL
,	NULL
Ben-Levy	NULL
,	NULL
R.	NULL
,	NULL
Ullrich	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Yarden	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2077-2086	NULL
Sadowski	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
and	NULL
Gilman	NULL
,	NULL
M.	NULL
Z	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
862	NULL
,	NULL
79-83	NULL
van	NULL
der	NULL
Bruggen	NULL
,	NULL
T.	NULL
,	NULL
Caldenhoven	NULL
,	NULL
E.	NULL
,	NULL
Kanters	NULL
,	NULL
D.	NULL
,	NULL
Raaijmakers	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
M.	NULL
,	NULL
Lammers	NULL
,	NULL
J.	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
Koenderman	NULL
,	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
1442-1448	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
,	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Sadowski	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
Gilman	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
366	NULL
,	NULL
580-583	NULL
Wagner	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Hayes	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Hoban	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Cochran	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
4477-4484	NULL
Decker	NULL
,	NULL
T.	NULL
,	NULL
Lew	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Mirkovitch	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
927-932	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
Feldman	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Igarashi	NULL
,	NULL
K.	NULL
,	NULL
Hackett	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Webb	NULL
,	NULL
D.	NULL
S.	NULL
A.	NULL
,	NULL
Sweitzer	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
III	NULL
,	NULL
and	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1730-1733	NULL
Ruff-Jamison	NULL
,	NULL
S.	NULL
,	NULL
Chen	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Cohen	NULL
,	NULL
S.	NULL
(	NULL
19983	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1733-1736	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Schlessinger	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1736-1739	NULL
Sadowski	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Gilman	NULL
,	NULL
M.	NULL
Z	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1739-1744	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
19983	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1744-1746	NULL
Khan	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Lindwall	NULL
,	NULL
G.	NULL
,	NULL
Maher	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Bothwell	NULL
,	NULL
A.	NULL
L.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
6806-6810	NULL
Greenlund	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Farrar	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Viviano	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
1591-1600	NULL
Hou	NULL
,	NULL
J.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Ho	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Brasseur	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1701-1706	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
95-98	NULL
Tian	NULL
,	NULL
S-8	NULL
.	NULL

,	NULL
Lamb	NULL
,	NULL
P.	NULL
,	NULL
Seidel	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Stein	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
1760-1764	NULL
Lamb	NULL
,	NULL
P.	NULL
,	NULL
Kessler	NULL
,	NULL
L.	NULL
V.	NULL
,	NULL
Suto	NULL
,	NULL
C.	NULL
,	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Seidel	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Stein	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
2063-2071	NULL
Ullrich	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Schlessinger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
203-212	NULL
Cui	NULL
,	NULL
Y.	NULL
,	NULL
Harvey	NULL
,	NULL
K.	NULL
,	NULL
Akard	NULL
,	NULL
L.	NULL
,	NULL
Jansen	NULL
,	NULL
J.	NULL
,	NULL
Hughes	NULL
,	NULL
C.	NULL
,	NULL
Siddiqui	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
English	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
5420-5428	NULL
McColl	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
DiPersio	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Caon	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Ho	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Naccache	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
1842-1852	NULL
Naccache	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Gilbert	NULL
,	NULL
C.	NULL
,	NULL
Caon	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Gaudry	NULL
,	NULL
M.	NULL
,	NULL
Huang	NULL
,	NULL
C-K.	NULL
,	NULL
Bonak	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
Umezawa	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
McColl	NULL
,	NULL
S.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Blood	NULL
76	NULL
,	NULL
2098-2104	NULL
Berkow	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Dodson	NULL
,	NULL
R.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Blood	NULL
75	NULL
,	NULL
2445-2452	NULL
Worthen	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
Avdi	NULL
,	NULL
N.	NULL
,	NULL
Buhl	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Suzuki	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

94	NULL
,	NULL
815-823	NULL
Naccache	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Jean	NULL
,	NULL
N.	NULL
,	NULL
Liao	NULL
,	NULL
N.	NULL
W.	NULL
,	NULL
Bator	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
McColl	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
and	NULL
Kubes	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
616-624	NULL
Kubes	NULL
,	NULL
P.	NULL
,	NULL
Suzuki	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Granger	NULL
,	NULL
D.	NULL
N.	NULL
(	NULL
1990	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

259	NULL
,	NULL
G859-GB64	NULL
Gomez-Cambronero	NULL
,	NULL
J.	NULL
,	NULL
Wang	NULL
,	NULL
E.	NULL
,	NULL
Johnson	NULL
,	NULL
G.	NULL
,	NULL
Huang	NULL
,	NULL
C-K.	NULL
,	NULL
and	NULL
Sha'afi	NULL
,	NULL
R.	NULL
I	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
6240-6245	NULL
Rollet	NULL
,	NULL
E.	NULL
,	NULL
Caon	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Roberge	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Liao	NULL
,	NULL
N.	NULL
W.	NULL
,	NULL
Malawista	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
McColl	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
and	NULL
Naccache	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
353-363	NULL
Okuda	NULL
,	NULL
K.	NULL
,	NULL
Druker	NULL
,	NULL
B.	NULL
,	NULL
Kanakura	NULL
,	NULL
Y.	NULL
,	NULL
Koenigsmann	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
1928-1935	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Granulocyte-Macrophage	NULL
Colony-stimulating	NULL
Factor	NULL
Stimulates	NULL
JAK2	NULL
Signaling	NULL
Pathway	NULL
and	NULL
Rapidly	NULL
Activates	NULL
p93	NULL
,	NULL
STAT1	NULL
p91	NULL
,	NULL
and	NULL
STAT3	NULL
p92	NULL
in	NULL
Polymorphonuclear	NULL
Leukocytes	NULL
Maria	NULL
F.	NULL
Brizzi	NULL
,	NULL
Maria	NULL
G.	NULL
Aronica	NULL
,	NULL
Arturo	NULL
Rosso	NULL
,	NULL
Gian	NULL
Paolo	NULL
Bagnara	NULL
,	NULL
Yosef	NULL
Yarden	NULL
and	NULL
Luigi	NULL
Pegoraro	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:3562-3567.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.7.3562	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/7/3562	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
63	NULL
references	NULL
,	NULL
42	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

